Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase III for Chondrosarcoma. According to GlobalData, Phase III drugs for Chondrosarcoma does not have sufficient ...

In the new study, patients diagnosed with the three main types of bile duct cancer (intrahepatic, perihilar or distal ...

One or more of the following drugs will also be offered depending on the genetic profile of the tumour: futibatinib, ivosidenib, zanidatamab, trastuzumab, neratinib, encorafenib and binimetinib.

Across patients with high-risk disease, median OS was significantly improved for the 4 patients who received an IDH1 inhibitor, either ivosidenib or olutasidenib, compared with the 28 patients who ...

Tibsovo is used in some adults to treat certain types of cancers, such as: Tibsovo comes as a tablet that you swallow, and its active ingredient is ivosidenib. (An active ingredient is what makes ...

Mark said: “Increasing understanding of biliary tract cancer has led to approval of the IDH1 inhibitor ivosidenib in metastatic cholangiocarcinoma (ClariDHy study). NICE approved this drug for use in ...

Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase I for Chronic Myelomonocytic Leukemia (CMML). According to GlobalData, Phase I drugs for Chronic ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

We are working with Guy’s and St. Thomas’ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms. We want to support clinicians in ensuring all patients are fully ...